BP
SQZ

BBR Partners’s SQZ Biotechnologies Company SQZ Stock Holding History

BBR Partners’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-73,599
Closed -$657K – 270
2021
Q4 		$657K Hold
73,599
– – 0.08% 101
2021
Q3 		$1.06M Hold
73,599
– – 0.09% 92
2021
Q2 		$1.06M Buy
+73,599
New +$961K 0.08% 90

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BBR Partners's SQZ Position: Q1 2022 in Review

BBR Partners sold out of SQZ Biotechnologies Company (SQZ) in Q1 2022, closing a stake of 73,599 shares — an estimated $657K sold.

BBR Partners first reported a position in SQZ in Q2 2021 and held it in 3 quarters. The position peaked at $1.06M in Q2 2021. 53 funds tracked by Wall St. Rank hold SQZ as of Q1 2022.

  • BBR Partners reported no remaining SQZ Biotechnologies Company position as of Q1 2022 after selling out during the quarter.
  • BBR Partners sold 73,599 SQZ Biotechnologies Company shares in Q1 2022, an estimated $657K.
  • BBR Partners first reported a position in SQZ Biotechnologies Company in Q2 2021 and held it in 3 quarters.
  • BBR Partners's SQZ Biotechnologies Company position peaked at $1.06M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q1 2022.

Based on BBR Partners's 13F filing for Q1 2022, filed 16 May 2022.